Efficacy and Tolerability of Current Treatments for Hormone-Refractory Prostate Cancer Patients with Visceral Metastases

Medicine, Enzalutamide, Docetaxel, Tolerability, Prostate cancer, Internal medicine, Oncology, Cabazitaxel, Refractory (planetary science), Chemotherapy, Androgen deprivation therapy, Cancer, Urology, Adverse effect, Androgen receptor